tirzepatide vials lilly Eli launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Lilly's Mounjaro tops other GLP-1s

A number of agents have been shown to reduce lipofuscin accumulation, including anti-helminthic flubendazole [65] and zinc [66] in human retinal pigment epithelium, rapamycin in animal cardiomyocytes [67] and murine hepatocytes [68]

This article first appeared on GuruFocus

Research shows GLP-1 therapy reduces appetite by 30 to 40% in postmenopausal women, independent of age-related metabolic changes

Diabetes (2003) 52(7):162734

Your coach should be analyzing self-monitoring data, identifying patterns in your adherence, adjusting targets based on your response, and preparing you for the inevitable first plateau

Yes, but listen to your body and stay hydrated.